Anastasios Dimou Selected Research

Chronic Renal Insufficiency

1/2015

Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular events.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anastasios Dimou Research Topics

Disease

12	Neoplasms (Cancer) 12/2023 - 10/2012
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 08/2011
7	Lung Neoplasms (Lung Cancer) 12/2023 - 07/2016
6	Melanoma (Melanoma, Malignant) 05/2024 - 11/2018
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2023
3	Adenocarcinoma of Lung 12/2022 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 06/2011 - 08/2009
2	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 06/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2013 - 09/2012
1	Hepatitis 02/2024
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023
1	Cytokine Release Syndrome 01/2023
1	Vesicular Stomatitis 01/2023
1	Uveal melanoma 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2020
1	Autoimmune Diseases (Autoimmune Disease) 03/2020
1	Intestinal Volvulus (Volvulus) 01/2020
1	Testicular Neoplasms (Testicular Cancer) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 04/2016
1	Pulmonary Embolism 11/2015
1	Diabetes Mellitus 01/2015
1	Pathologic Constriction (Stenosis) 01/2015
1	Thrombosis (Thrombus) 01/2015
1	Chronic Renal Insufficiency 01/2015
1	Proteinuria 01/2015
1	Acute Coronary Syndrome 01/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2014
1	Atherosclerosis 01/2014
1	Venous Thromboembolism 01/2014
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 09/2013
1	Primitive Neuroectodermal Tumors (PNET) 07/2013
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2013
1	Breast Neoplasms (Breast Cancer) 10/2012

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2012
4	ErbB Receptors (EGF Receptor)IBA 08/2021 - 06/2011
3	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2019
2	LigandsIBA 12/2023 - 01/2019
2	entrectinibIBA 11/2023 - 01/2023
2	CrizotinibIBA 11/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2016
2	Rituximab (Mabthera)FDA Link 01/2022 - 03/2020
2	osimertinibIBA 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2014 - 01/2014
2	Angiotensin Receptor AntagonistsIBA 12/2014 - 01/2014
2	Bevacizumab (Avastin)FDA Link 07/2013 - 06/2010
1	IpilimumabIBA 05/2024
1	NivolumabIBA 05/2024
1	cobimetinibIBA 02/2024
1	VemurafenibIBA 02/2024
1	atezolizumabIBA 02/2024
1	Protons (Proton)IBA 02/2024
1	PM 01183IBA 12/2023
1	Interferon-betaIBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	taletrectinibIBA 01/2023
1	sotorasibIBA 01/2023
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2023
1	COVID-19 VaccinesIBA 12/2022
1	pralsetinibIBA 12/2022
1	Gefitinib (Iressa)FDA Link 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	trametinibIBA 03/2020
1	dabrafenibIBA 03/2020
1	AntigensIBA 01/2020
1	GoldIBA 01/2019
1	lorlatinibIBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 11/2018
1	Formaldehyde (Formol)FDA Link 04/2016
1	ParaffinIBA 04/2016
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 11/2015
1	Proton Pump InhibitorsIBA 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015
1	Clopidogrel (Plavix)FDA Link 01/2015
1	AlbuminsIBA 01/2015
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2014
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2014
1	Hormones (Hormone)IBA 01/2014
1	ReninIBA 01/2014
1	AngiotensinsIBA 01/2014
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 09/2013
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2013
1	pasireotideIBA 07/2013
1	temsirolimus FDA Link 07/2013
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2013
1	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2013
1	pamrevlumabIBA 03/2013
1	ASG-5MEIBA 03/2013
1	tanespimycin (17AAG)IBA 03/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2013
1	Connective Tissue Growth FactorIBA 03/2013
1	Aldehyde Dehydrogenase 1 FamilyIBA 10/2012

Therapy/Procedure

9	Therapeutics 02/2024 - 07/2013
6	Immunotherapy 05/2024 - 07/2016
2	Drug Therapy (Chemotherapy) 12/2023 - 03/2013
2	Radiotherapy 03/2020 - 08/2009
1	Craniospinal Irradiation 02/2024
1	Neoadjuvant Therapy 03/2019
1	Stents 01/2015